BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 10/14/2017 |
| Start Date: | November 2006 |
| End Date: | February 2009 |
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients
The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the
first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight
loss at the end of the second year of treatment (Week 104)
first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight
loss at the end of the second year of treatment (Week 104)
Inclusion Criteria:
- Obese adults with a BMI 30 to 45 kg/m2 or overweight adults with a BMI 27 to 29.9
kg/m2 and at least one obesity-related comorbidity (hypertension, dyslipidemia,
cardiovascular disease, glucose intolerance, sleep apnea)
- Ability to complete a 2 year study
Exclusion Criteria:
- Diabetes
- Pregnancy
- History of heart valve disease
- Serious or unstable current or past medical conditions
We found this trial at
1
site
Click here to add this to my saved trials
